Authors failing to disclose competing interests
Despite strict disclosure policies, some authors writing for highly respected medical journals still keep their financial interests to themselves, according to a report by the Center for Science in the Public Interest, a Washington-based pressure group. After researching the financial connections of the authors of 163 articles in four journals, the CSPI found that 13 (8%) failed to comply with disclosure policies. The authors of one paper on coronary heart disease were consultants to more than 20 companies in the field, but failed to disclose them. However, the situation actually may be improving. In 2001, only 1% of papers disclosed a conflict, a figure which has apparently risen to 20% currently.
Latest posts by Mumbai (see all)
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
Commercial surrogacy hammered in Rome
Momentum in growing in Europe for a global ban on surrogacy. Italy’s Prime Minister, Giorgia Meloni has blasted surrogacy as...
Canadian man wins right to a government-funded ‘penile-preserving vaginoplasty’
An Ontario man has won the right to government-funded gender-affirming surgery in the United States which will give him both...
14-year-olds will be able to change their gender legally in Germany
German lawmakers have made it easier for transgender, intersex and non-binary people to change their official gender. A controversial Self-Determination...
Gaza’s IVF embryos have been destroyed by Israeli bombs
One of the many casualties of the war in Gaza has been the embryos and gametes stored at the Al-Basma IVF...
UK doctors fear toxic abuse over their research on trans issues
Fallout from the Cass review of transgender medical treatment in the UK continues. The Guardian interviewed doctors and researchers who...
Utah’s new stem cell law undermines FDA’s authority
The state of Utah has just enacted a law permitting patients to receive medical treatments using placental stem cells without formal approval...
